HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-APR-19 6OP9 TITLE HER3 PSEUDOKINASE DOMAIN BOUND TO BOSUTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTO-ONCOGENE-LIKE PROTEIN C-ERBB-3,TYROSINE KINASE-TYPE COMPND 5 CELL SURFACE RECEPTOR HER3; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ERBB3, HER3; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS RECEPTOR TYROSINE KINASE, PSEUDOKINASE, BOSUTINIB, MEMBRANE, KEYWDS 2 SIGNALING PROTEIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.LITTLEFIELD,C.AGNEW,N.JURA REVDAT 3 22-MAY-24 6OP9 1 REMARK REVDAT 2 16-FEB-22 6OP9 1 JRNL REVDAT 1 21-AUG-19 6OP9 0 SPRSDE 21-AUG-19 6OP9 4OTW JRNL AUTH M.R.CAMPBELL,A.RUIZ-SAENZ,E.PETERSON,C.AGNEW,P.AYAZ, JRNL AUTH 2 S.GARFINKLE,P.LITTLEFIELD,V.STERI,J.OEFFINGER,M.SAMPANG, JRNL AUTH 3 Y.SHAN,D.E.SHAW,N.JURA,M.M.MOASSER JRNL TITL TARGETABLE HER3 FUNCTIONS DRIVING TUMORIGENIC SIGNALING IN JRNL TITL 2 HER2-AMPLIFIED CANCERS. JRNL REF CELL REP V. 38 10291 2022 JRNL REFN ESSN 2211-1247 JRNL PMID 35108525 JRNL DOI 10.1016/J.CELREP.2021.110291 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 15679 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 761 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.1544 - 4.2756 1.00 3117 169 0.1637 0.1998 REMARK 3 2 4.2756 - 3.3942 1.00 3063 155 0.1531 0.2292 REMARK 3 3 3.3942 - 2.9653 1.00 2995 152 0.1774 0.2574 REMARK 3 4 2.9653 - 2.6942 1.00 3046 147 0.1974 0.2628 REMARK 3 5 2.6942 - 2.5011 0.90 2697 138 0.1978 0.2536 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2221 REMARK 3 ANGLE : 0.929 3026 REMARK 3 CHIRALITY : 0.050 342 REMARK 3 PLANARITY : 0.006 378 REMARK 3 DIHEDRAL : 8.197 1792 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OP9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-APR-19. REMARK 100 THE DEPOSITION ID IS D_1000241107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11587 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15679 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.501 REMARK 200 RESOLUTION RANGE LOW (A) : 41.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : 0.14100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.59600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 20000, 0.1M MES, PH 6.7, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 19.39800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 38.79600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 38.79600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 19.39800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 655 REMARK 465 ARG A 656 REMARK 465 ALA A 657 REMARK 465 MET A 658 REMARK 465 ARG A 659 REMARK 465 ARG A 660 REMARK 465 TYR A 661 REMARK 465 LEU A 662 REMARK 465 GLU A 663 REMARK 465 ARG A 664 REMARK 465 GLY A 665 REMARK 465 GLU A 666 REMARK 465 SER A 667 REMARK 465 ILE A 668 REMARK 465 GLU A 669 REMARK 465 PRO A 670 REMARK 465 LEU A 671 REMARK 465 ASP A 672 REMARK 465 PRO A 673 REMARK 465 SER A 674 REMARK 465 GLU A 675 REMARK 465 LYS A 676 REMARK 465 ALA A 677 REMARK 465 ASN A 678 REMARK 465 LYS A 679 REMARK 465 LEU A 847 REMARK 465 LEU A 848 REMARK 465 TYR A 849 REMARK 465 SER A 850 REMARK 465 GLU A 851 REMARK 465 ARG A 961 REMARK 465 GLU A 962 REMARK 465 SER A 963 REMARK 465 GLY A 964 REMARK 465 PRO A 965 REMARK 465 GLY A 966 REMARK 465 ILE A 967 REMARK 465 ALA A 968 REMARK 465 PRO A 969 REMARK 465 GLY A 970 REMARK 465 PRO A 971 REMARK 465 GLU A 972 REMARK 465 PRO A 973 REMARK 465 HIS A 974 REMARK 465 GLY A 975 REMARK 465 LEU A 976 REMARK 465 THR A 977 REMARK 465 ASN A 978 REMARK 465 LYS A 979 REMARK 465 LYS A 980 REMARK 465 LEU A 981 REMARK 465 GLU A 982 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 686 CG CD CE NZ REMARK 470 ARG A 691 CD NE CZ NH1 NH2 REMARK 470 LYS A 694 CG CD CE NZ REMARK 470 GLU A 712 CG CD OE1 OE2 REMARK 470 LYS A 717 CD CE NZ REMARK 470 LYS A 824 CE NZ REMARK 470 ASP A 843 CG OD1 OD2 REMARK 470 ASP A 844 CG OD1 OD2 REMARK 470 GLN A 846 CG CD OE1 NE2 REMARK 470 LYS A 853 CG CD CE NZ REMARK 470 ARG A 897 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 900 CG CD OE1 OE2 REMARK 470 LYS A 927 CD CE NZ REMARK 470 LYS A 940 CE NZ REMARK 470 ARG A 948 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 960 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 701 36.77 -91.32 REMARK 500 ARG A 784 -137.43 49.16 REMARK 500 ASN A 815 41.06 -155.32 REMARK 500 ASP A 952 72.33 -152.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DB8 A 1101 DBREF 6OP9 A 655 982 UNP P21860 ERBB3_HUMAN 674 1001 SEQRES 1 A 328 LYS ARG ALA MET ARG ARG TYR LEU GLU ARG GLY GLU SER SEQRES 2 A 328 ILE GLU PRO LEU ASP PRO SER GLU LYS ALA ASN LYS VAL SEQRES 3 A 328 LEU ALA ARG ILE PHE LYS GLU THR GLU LEU ARG LYS LEU SEQRES 4 A 328 LYS VAL LEU GLY SER GLY VAL PHE GLY THR VAL HIS LYS SEQRES 5 A 328 GLY VAL TRP ILE PRO GLU GLY GLU SER ILE LYS ILE PRO SEQRES 6 A 328 VAL CYS ILE LYS VAL ILE GLU ASP LYS SER GLY ARG GLN SEQRES 7 A 328 SER PHE GLN ALA VAL THR ASP HIS MET LEU ALA ILE GLY SEQRES 8 A 328 SER LEU ASP HIS ALA HIS ILE VAL ARG LEU LEU GLY LEU SEQRES 9 A 328 CYS PRO GLY SER SER LEU GLN LEU VAL THR GLN TYR LEU SEQRES 10 A 328 PRO LEU GLY SER LEU LEU ASP HIS VAL ARG GLN HIS ARG SEQRES 11 A 328 GLY ALA LEU GLY PRO GLN LEU LEU LEU ASN TRP GLY VAL SEQRES 12 A 328 GLN ILE ALA LYS GLY MET TYR TYR LEU GLU GLU HIS GLY SEQRES 13 A 328 MET VAL HIS ARG ASN LEU ALA ALA ARG ASN VAL LEU LEU SEQRES 14 A 328 LYS SER PRO SER GLN VAL GLN VAL ALA ASP PHE GLY VAL SEQRES 15 A 328 ALA ASP LEU LEU PRO PRO ASP ASP LYS GLN LEU LEU TYR SEQRES 16 A 328 SER GLU ALA LYS THR PRO ILE LYS TRP MET ALA LEU GLU SEQRES 17 A 328 SER ILE HIS PHE GLY LYS TYR THR HIS GLN SER ASP VAL SEQRES 18 A 328 TRP SER TYR GLY VAL THR VAL TRP GLU LEU MET THR PHE SEQRES 19 A 328 GLY ALA GLU PRO TYR ALA GLY LEU ARG LEU ALA GLU VAL SEQRES 20 A 328 PRO ASP LEU LEU GLU LYS GLY GLU ARG LEU ALA GLN PRO SEQRES 21 A 328 GLN ILE CYS THR ILE ASP VAL TYR MET VAL MET VAL LYS SEQRES 22 A 328 CYS TRP MET ILE ASP GLU ASN ILE ARG PRO THR PHE LYS SEQRES 23 A 328 GLU LEU ALA ASN GLU PHE THR ARG MET ALA ARG ASP PRO SEQRES 24 A 328 PRO ARG TYR LEU VAL ILE LYS ARG GLU SER GLY PRO GLY SEQRES 25 A 328 ILE ALA PRO GLY PRO GLU PRO HIS GLY LEU THR ASN LYS SEQRES 26 A 328 LYS LEU GLU HET DB8 A1101 36 HETNAM DB8 4-[(2,4-DICHLORO-5-METHOXYPHENYL)AMINO]-6-METHOXY-7-[3- HETNAM 2 DB8 (4-METHYLPIPERAZIN-1-YL)PROPOXY]QUINOLINE-3- HETNAM 3 DB8 CARBONITRILE HETSYN DB8 BOSUTINIB FORMUL 2 DB8 C26 H29 CL2 N5 O3 FORMUL 3 HOH *89(H2 O) HELIX 1 AA1 LYS A 686 THR A 688 5 3 HELIX 2 AA2 THR A 738 SER A 746 1 9 HELIX 3 AA3 SER A 775 ARG A 784 1 10 HELIX 4 AA4 GLY A 785 LEU A 787 5 3 HELIX 5 AA5 GLY A 788 HIS A 809 1 22 HELIX 6 AA6 ALA A 817 ARG A 819 5 3 HELIX 7 AA7 VAL A 836 LEU A 840 5 5 HELIX 8 AA8 PRO A 855 MET A 859 5 5 HELIX 9 AA9 ALA A 860 GLY A 867 1 8 HELIX 10 AB1 THR A 870 THR A 887 1 18 HELIX 11 AB2 ARG A 897 ALA A 899 5 3 HELIX 12 AB3 GLU A 900 LYS A 907 1 8 HELIX 13 AB4 THR A 918 TRP A 929 1 12 HELIX 14 AB5 THR A 938 ARG A 951 1 14 HELIX 15 AB6 ASP A 952 TYR A 956 5 5 SHEET 1 AA1 6 ARG A 683 ILE A 684 0 SHEET 2 AA1 6 LEU A 755 CYS A 759 1 O LEU A 756 N ARG A 683 SHEET 3 AA1 6 LEU A 764 GLN A 769 -1 O VAL A 767 N GLY A 757 SHEET 4 AA1 6 ILE A 718 ILE A 725 -1 N ILE A 725 O LEU A 764 SHEET 5 AA1 6 THR A 703 TRP A 709 -1 N HIS A 705 O ILE A 722 SHEET 6 AA1 6 LEU A 690 SER A 698 -1 N LEU A 693 O LYS A 706 SHEET 1 AA2 2 VAL A 821 LEU A 823 0 SHEET 2 AA2 2 VAL A 829 VAL A 831 -1 O GLN A 830 N LEU A 822 SITE 1 AC1 12 LEU A 696 CYS A 721 LYS A 723 VAL A 753 SITE 2 AC1 12 LEU A 766 THR A 768 GLN A 769 LEU A 771 SITE 3 AC1 12 PRO A 772 LEU A 822 ASP A 833 HOH A1251 CRYST1 116.385 116.385 58.194 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008592 0.004961 0.000000 0.00000 SCALE2 0.000000 0.009921 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017184 0.00000